Medical Packaging Company Signs $200 Million Syringe Sales Agreement
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Readers should perform their own research and consult a professional financial advisor before making any investment decisions.